Loading…
Operator of occupational health clinics providing workplace injury care, physical therapy and employer health services.
Operator of occupational health clinics providing workplace injury care, physical therapy and employer health services.
Is paid mainly by employers and by workers' compensation insurers, which cover injured workers' care at rates set by state fee schedules, while services such as drug testing and pre-hire physicals are billed directly to employers. Select Medical floated it in 2024 and then distributed its remaining shares to its own shareholders.
In one line: The largest US occupational-health clinic operator.
Moat: narrow (scale, distribution, brand). Largest US occupational-health clinic network and long-standing employer relationships create scale advantage.
Headquarters: Addison, Texas · Founded: 1979 · Employees: 13,133
Size Concentra Group Holdings Parent (CON) is a United States Health Care company (Medical/Nursing Services) with a market value of $5.38B, the 1131st largest of 3,117 United States companies the cockpit tracks. Shares closed at $42.22 on 6 Nov 2026.
Performance Over six months the shares gained 74.8%, against +25.8% for the median peer and -1.1% for the United States market (cap-weighted) — 4th highest of 20 in its peer set.
Growth Revenue grew 14.0% over the last twelve months (peer median +11.3%); the operating margin is 16.7% (peer median 9.5%).
Valuation It trades at 24.5× forward earnings against a peer median of 29.5× (10th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 5.1 points above its cost of capital (6.8% WACC).
Short interest Short interest is 2.8% of the free float (15 Oct 2026).
Next results Next results expected around 8 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.29B | $2.16B | $1.90B | $1.84B | $1.72B |
| Revenue growth | — | +14% | +3% | +7% | — |
| Gross profit | $591M | $537M | $461M | $439M | $408M |
| EBITDA | $462M | $421M | $372M | $360M | $332M |
| Net income | $196M | $166M | $167M | $180M | $167M |
| Free cash flow | $267M | $197M | $210M | $165M | $228M |
| Capital expenditure | $68.1M | $82.3M | $64.3M | $69.3M | $46.0M |
| Total debt | $2.14B | $2.10B | $1.95B | $905M | $1.04B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Concentra Group Holdings Parent CON | $5.38B | +75% | +14% | 17% | 24.5× | 3.9% |
| U.S. Physical Therapy USPH | $1.48B | +68% | +11% | 10% | 30.4× | 19.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CON | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +15.3% | +9.3% | 4th highest of 21 |
| 6-month return | +74.8% | +25.8% | 4th highest of 20 |
| Distance from 52-week high | -4.5% | -13.0% | 2nd highest of 21 |
| Revenue growth (TTM) | +14.0% | +11.3% | 10th highest of 21 |
| Operating margin | 16.7% | 9.5% | 3rd highest of 21 |
| Forward P/E | 24.5× | 29.5× | 10th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 3.9% | 12.7% | 5th least demanding of 19 |
| Growth delivered (Del g) | +7.9% | +13.3% | 6th lowest of 19 |
| Hurdle (Req g minus delivered) | -4.0 pp | -0.8 pp | 9th least demanding of 19 |
| ROIC minus cost of capital | +5.1 pp | +1.4 pp | 6th highest of 21 |
| EV / EBITDA | 16.0× | 13.2× | 7th most expensive of 16 |
| Net debt / EBITDA | 4.3× | 2.8× | 7th most indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Concentra Group Holdings Parent CON | United States | $5.38B | +75% | +14% | 17% | 24.5× | 3.9% | +7.9% |
| BillionToOne BLLN | United States | $5.38B | +54% | +90% | 11% | 144.4× | 26.8% | +90.1% |
| Lifestance Health LFST | United States | $5.26B | +79% | +20% | 5% | 62.6× | 37.8% | +30.4% |
| RadNet RDNT | United States | $5.98B | +31% | +19% | 5% | 129.7× | 41.8% | +13.7% |
| Hims & Hers Health HIMS | United States | $6.07B | -8% | +28% | 0% | 128.9× | 54.9% | +73.6% |
| Option Care Health OPCH | United States | $4.74B | +54% | +4% | 6% | 15.6× | 1.5% | +13.2% |
| Sonic Healthcare SHL.AX | Australia | $6.87B | +6% | +14% | 9% | 16.8× | 8.6% | +3.5% |
| Medicover MCOV-B.ST | Sweden | $4.14B | +36% | +6% | 7% | 38.3× | 20.8% | +20.2% |
| Dr. Lal PathLabs LALPATHLAB.NS | India | $3.50B | +26% | +17% | 24% | 51.5× | 32.2% | +11.8% |
| Acadia Healthcare ACHC | United States | $3.44B | +47% | +4% | 10% | 18.7× | n/a | n/a |
| Fameglow 3774.HK | Hong Kong | $3.19B | n/a | +36% | 11% | n/a | 48.8% | +48.4% |
| Meinian Onehealth Healthcare 002044.SZ | China | $2.89B | -9% | -4% | 9% | 55.1× | 5.8% | +5.7% |
| Aveanna Healthcare AVAH | United States | $2.89B | +97% | +20% | 11% | 15.4× | 13.4% | +10.2% |
| Ensign ENSG | United States | $10.6B | +6% | +17% | 9% | 21.1× | 12.0% | +16.5% |
| Pediatrix Medical MD | United States | $2.44B | +33% | +2% | 12% | 12.9× | -4.5% | +2.0% |
| DaVita DVA | United States | $12.0B | -4% | +6% | 15% | 11.9× | -1.1% | +3.4% |
| Aier Eye Hospital 300015.SZ | China | $12.5B | -16% | +5% | 21% | 29.5× | 11.7% | +13.4% |
| Addus HomeCare ADUS | United States | $2.32B | +25% | +12% | 11% | 16.6× | 4.9% | +13.2% |
| Fresenius Medical Care FME.DE | Germany | $12.6B | +14% | 0% | 11% | 10.4× | -3.6% | +1.9% |
| AddLife ALIF-B.ST | Sweden | $2.29B | +25% | +2% | 8% | 40.5× | 21.6% | +14.6% |
| NeoGenomics NEO | United States | $2.18B | +88% | +11% | -6% | 58.9× | n/a | n/a |